BSE filing, NSE: GPTHEALTH. Summary written from the filing by ALFA Finder's alert engine.
GPT Healthcare Ltd: key numbers
- Share price
- ₹135.00
- Market cap
- ₹1,108 Cr
- Revenue (annual)
- ₹472.6 Cr
- Net profit (annual)
- ₹42.22 Cr
- P/E (TTM)
- 23.4×Sector 51.1×
- Promoter holding
- 65.57%+0.00% QoQ
- FII holding
- 3.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GPT Healthcare Ltd
All →GPT Healthcare Board Meeting Date
GPT Healthcare will hold a board meeting on 05 Nov 2026 to consider Q2 and half-year unaudited results and a possible interim dividend for FY 2026-27. Trading window stays closed until 07 Nov 2026.
GPT Healthcare Annual General Meeting
GPT Healthcare Limited held its 37th Annual General Meeting on August 6, 2026. Shareholders transacted ordinary and special business items as stated in the notice.
GPT Healthcare Earnings Call Transcript: Key Takeaways
GPT Healthcare shows strong 18.2% revenue growth and 66% PAT growth, but struggles with utilization outside its core Kolkata market.
GPT Healthcare Results Update
GPT Healthcare reported Q1 FY27 financial results. Total income grew 18% year-over-year to ₹128.2 Crore, reflecting steady operational performance.
GPT Healthcare Investor Presentation: Key Takeaways
GPT Healthcare reported Q1FY27 revenue of ₹126.2 Cr, up 17.8% YoY, with EBITDA margins improving to 20.4%. The company is executing a proximity-based model in Eastern India.
GPT Healthcare Q1 FY27 Results: Net Profit ₹12.7 Cr, Up 64.9% YoY
GPT Healthcare Ltd reported revenue from operations of ₹126.2 Cr (+17.8% YoY) and net profit of ₹12.7 Cr (+64.9% YoY) for Q1 FY27.
- Key figure
- Net profit ₹12.7 Cr · +64.9% YoY
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.